blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3830556

EP3830556 - KITS, MICROFLUIDICS DEVICES, AND METHODS FOR PERFORMING BIOTIN ASSAYS [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  03.06.2024
Database last updated on 24.08.2024
FormerExamination is in progress
Status updated on  07.07.2022
FormerRequest for examination was made
Status updated on  07.05.2021
FormerThe international publication has been made
Status updated on  08.02.2020
Most recent event   Tooltip20.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Siemens Healthcare Diagnostics Inc.
511 Benedict Avenue
Tarrytown, NY 10591 / US
[2021/23]
Inventor(s)01 / WEI, Tie Q.
97 Ascension Drive
Wilmington, Delaware 19808 / US
02 / TENG, Zhu
1201 Woodsview Drive
Garnet Valley, Pennsylvania 19060 / US
03 / LIU, Xiaodong
601 Coralberry Ct.
Wilmington, Delaware 19808 / US
04 / DRINAN, Martin
719 Lehigh Road
Newark, Delaware 19711 / US
 [2021/23]
Representative(s)Schweitzer, Klaus
Plate Schweitzer Zounek Patentanwälte Rheingaustrasse 196
65203 Wiesbaden / DE
[2021/23]
Application number, filing date19844762.524.07.2019
[2021/23]
WO2019US43195
Priority number, dateUS201862711694P30.07.2018         Original published format: US 201862711694 P
[2021/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020028110
Date:06.02.2020
Language:EN
[2020/06]
Type: A1 Application with search report 
No.:EP3830556
Date:09.06.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 06.02.2020 takes the place of the publication of the European patent application.
[2021/23]
Search report(s)International search report - published on:US06.02.2020
(Supplementary) European search report - dispatched on:EP30.07.2021
ClassificationIPC:G01N21/76, G01N33/58, F21K2/06, B01L3/00
[2021/23]
CPC:
F21K2/06 (EP); G01N33/582 (US); B01L3/502715 (US);
C09K11/07 (EP); G01N21/76 (US); G01N33/542 (EP);
G01N33/566 (EP); G01N33/58 (EP); G01N33/583 (EP);
B01L2200/027 (US); B01L2200/16 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/23]
TitleGerman:KITS, MIKROFLUIDISCHE VORRICHTUNGEN UND VERFAHREN ZUR DURCHFÜHRUNG VON BIOTINTESTS[2021/23]
English:KITS, MICROFLUIDICS DEVICES, AND METHODS FOR PERFORMING BIOTIN ASSAYS[2021/23]
French:KITS, DISPOSITIFS MICROFLUIDIQUES ET PROCÉDÉS DESTINÉS À EFFECTUER DES DOSAGES DE BIOTINE[2021/23]
Entry into regional phase26.02.2021National basic fee paid 
26.02.2021Search fee paid 
26.02.2021Designation fee(s) paid 
26.02.2021Examination fee paid 
Examination procedure26.02.2021Examination requested  [2021/23]
24.02.2022Amendment by applicant (claims and/or description)
06.07.2022Despatch of a communication from the examining division (Time limit: M04)
13.10.2022Reply to a communication from the examining division
01.02.2023Despatch of a communication from the examining division (Time limit: M04)
15.05.2023Reply to a communication from the examining division
21.09.2023Despatch of a communication from the examining division (Time limit: M04)
04.01.2024Reply to a communication from the examining division
04.06.2024Communication of intention to grant the patent
Fees paidRenewal fee
19.07.2021Renewal fee patent year 03
19.07.2022Renewal fee patent year 04
19.07.2023Renewal fee patent year 05
19.07.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2005080989  (MOLECULAR PROBES INC [US], et al) [Y] 1-15 * examples 6, 8; claims 1-33 *;
 [Y]  - ULLMAN E F ET AL, "Luminescent oxygen channeling assay (LOCI (tm)): sensitive, broadly applicable homogeneous immunoassay method", CLINICAL CHEMISTRY, OXFORD UNIVERSITY PRESS, US, (19960101), vol. 42, no. 9, ISSN 0009-9147, pages 1518 - 1526, XP002109518 [Y] 1-15 * Page 1520 last paragraph - page 1521 last paragraph; page 1518 - page 1519; figures 3,4 *
 [A]  - CLAIRE E CHIVERS ET AL, "A streptavidin variant with slower biotin dissociation and increased mechanostability", NATURE METHODS, NATURE PUB. GROUP, NEW YORK, vol. 7, no. 5, doi:10.1038/NMETH.1450, ISSN 1548-7091, (20100501), pages 391 - 393, (20100411), XP002617243 [A] 1-15

DOI:   http://dx.doi.org/10.1038/nmeth.1450
International search[Y]US2012077284  (SOLDO JOSHUA C [US], et al) [Y] 2, 3, 8, 9, 14, 17, 18, 23, 25* ; Abstract; Paragraphs [0016], [0194], [0196], [0203] *;
 [Y]US2014154700  (TENG ZHU [US], et al) [Y] 7-13, 15-32 * ; Abstract; Paragraphs [0035], [0050], [0051], [0062]; Claim 3 *;
 [Y]US2016033417  (LEDDEN DAVID J [US]) [Y] 1-32 * ; Abstract; Paragraphs [0024], [0037], [0046], [0051], [0052], [0056]; Claims 1, 5, 8, 15, 20, 33, 43, 47 *;
 [Y]US2018003700  (FOGELSTRAND PER [SE], et al) [Y] 1-6, 14 * ; Abstract; Paragraph [0018] *
by applicantUS5340716
 US5538834
 US5545834
 US5578498
 US5618732
 US5672478
 US5709994
 US5780646
 US5811311
 US5929049
 US5936070
 US6002000
 US6143514
 US6180354
 US6251581
 US6340599
 US6406913
 US6406667
 US6489309
 US6692975
 US6703248
 US6797481
 US6916667
 US6949524
 US7022529
 US7033775
 US7101682
 US7179660
 US7229842
 US7709273
 US9244085
 US9416776
    - AUBRY, J. Am. Chem. Soc., (19850000), vol. 107, pages 5844 - 5849
    - AUBRY, J. Org. Chem., (19890000), vol. 54, pages 726 - 728
    - BOHMEBRAUER, Inorg. Chem., (19920000), vol. 31, pages 3468 - 3471
    - NIUFOOTE, Inorg. Chem.,, (19920000), vol. 31, pages 3472 - 3476
    - NARDELLO et al., Inorg. Chem., (19950000), vol. 34, pages 4950 - 4957
    - AUBRYBOUTTEMY, J. Am. Chem. Soc., (19970000), vol. 119, pages 5286 - 5294
    - ALMEIDA et al., Anal. Chim. Acta, (20030000), vol. 482, pages 99 - 104
    - ATHAPPILLY et al., Protein Science, (19970000), vol. 6, pages 1338 - 1342
    - TORREGGIANI, Biospectroscopy, (19980000), vol. 4, pages 197 - 208
    - LEVERT et al., J Biol Chem, (20020000), vol. 277, pages 16347 - 16350
    - YAMAMOTO et al., Chem Asian J, (20150000), vol. 10, pages 1071 - 8
    - KANG et al., J Drug Target, (19950000), vol. 3, pages 159 - 65
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.